| CAS No. | 320416-09-9 |
| Molecular Formula | C18H17N7O |
| Molecular Weight | 347.37 g/mol |
| Category | Pharmaceutical Standards / API Standards |
| Availability | In Stock |
4-{7-[4-(1H-imidazol-1-yl)phenyl]-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl}morpholine (CAS 320416-09-9), molecular formula C18H17N7O and molecular weight 347.37 g/mol, is a CATO reference standard with documented purity and traceability.
The molecular framework of 4-{7-[4-(1H-imidazol-1-yl)phenyl]-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl}morpholine (C18H17N7O) is characterized by a steroid core, an amide group, a hydroxyl group, an ether linkage. In reversed-phase chromatography, its retention is governed primarily by the protonation state of its nitrogen-containing groups, which provides a practical basis for HPLC-UV/DAD or LC-MS method development. The aromatic system may exhibit native fluorescence, enabling detection with a fluorescence detector (FLD).
Recommended for analytical method development and validation; each product is supplied with a full Certificate of Analysis (COA) ensuring ISO 17034 metrological traceability.
As a certified reference material (CRM), 4-{7-[4-(1H-imidazol-1-yl)phenyl]-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl}morpholine meets the metrological traceability requirements of ISO/IEC 17025 laboratories. Batch-to-batch consistency is monitored via control charts to guarantee comparable assigned values across lots.
| Molecular Formula | C18H17N7O |
| Molecular Weight | 347.37 g/mol |
| Appearance | Pale yellow to yellow crystalline powder |
| Purity | 97%+ |
| Storage | Store at 2-8°C, protect from light |
| Solubility (reference) | Soluble in DMSO, DMF, methanol |
| Stability | Light-sensitive; avoid direct strong light |
| Degree of Unsaturation (DBE) | 14.0 |
| UV Absorption | UV-absorbing |
| Structural Features | Aromatic ring present |
| CAS Registry Year (est.) | 2025 |
| Nitrogen Atoms | 7 |